| # | Title | Journal | Year | Citations |
|---|
| 1 | Head and neck cancer: past, present and future | Expert Review of Anticancer Therapy | 2006 | 199 |
| 2 | Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial | Lancet Oncology, The | 2021 | 183 |
| 3 | Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes | Head and Neck | 2007 | 170 |
| 4 | Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group | Lancet Oncology, The | 2015 | 170 |
| 5 | Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation | Head and Neck | 2009 | 156 |
| 6 | Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement | International Journal of Radiation Oncology Biology Physics | 2020 | 156 |
| 7 | Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer | Radiotherapy and Oncology | 2009 | 113 |
| 8 | Utility of 68Ga prostate specific membrane antigen – positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma | Journal of Medical Imaging and Radiation Oncology | 2017 | 83 |
| 9 | Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response | Annals of Surgical Oncology | 2008 | 68 |
| 10 | Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas | Neuro-Oncology | 2020 | 62 |
| 11 | Fiducial markers and spacers in prostate radiotherapy: current applications | BJU International | 2014 | 55 |
| 12 | Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone | Radiotherapy and Oncology | 2008 | 50 |
| 13 | Circulating tumor cell detection in high-risk non-metastatic prostate cancer | Journal of Cancer Research and Clinical Oncology | 2014 | 50 |
| 14 | Adjuvant Chemoradiation for Gastric Cancer Using Epirubicin, Cisplatin, and 5-Fluorouracil Before and After Three-Dimensional Conformal Radiotherapy With Concurrent Infusional 5-Fluorouracil: A Multicenter Study of the Trans-Tasman Radiation Oncology Group | International Journal of Radiation Oncology Biology Physics | 2011 | 49 |
| 15 | Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy | Ecological Management and Restoration | 2007 | 48 |
| 16 | Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases | JAMA Oncology | 2020 | 47 |
| 17 | Radiotherapy‐associated dental extractions and osteoradionecrosis | Head and Neck | 2017 | 42 |
| 18 | Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group | Radiotherapy and Oncology | 2018 | 39 |
| 19 | Guidelines for safe practice of stereotactic body (ablative) radiation therapy | Journal of Medical Imaging and Radiation Oncology | 2015 | 37 |
| 20 | Measuring head and neck lymphedema: The “ALOHA” trial | Head and Neck | 2016 | 37 |
| 21 | Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer | British Journal of Cancer | 2007 | 35 |
| 22 | Consensus Statement on Palliative Lung Radiotherapy: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control | Clinical Lung Cancer | 2012 | 32 |
| 23 | Development of an International Prostate Cancer Outcomes Registry | BJU International | 2016 | 31 |
| 24 | Achieving success in clinically based research: the importance of mentoring | Journal of Medical Radiation Sciences | 2017 | 30 |
| 25 | The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases | Expert Review of Anticancer Therapy | 2018 | 30 |
| 26 | Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: Retrospective review | Journal of Medical Imaging and Radiation Oncology | 2008 | 29 |
| 27 | Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case–case comparison | International Journal of Cancer | 2017 | 26 |
| 28 | Strategy in the Surgical Treatment of Primary Spinal Tumors | Global Spine Journal | 2012 | 25 |
| 29 | Radiotherapy for cutaneous melanoma: current and future applications | Future Oncology | 2015 | 25 |
| 30 | Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement | Radiotherapy and Oncology | 2020 | 24 |
| 31 | Waiting times for radiotherapy—a survey of patients' attitudes | Radiotherapy and Oncology | 2004 | 23 |
| 32 | Pathologic Occult Neck Disease in Patients With Metastatic Cutaneous Squamous Cell Carcinoma to the Parotid | Otolaryngology - Head and Neck Surgery | 2011 | 23 |
| 33 | Non‐small cell lung cancer brain metastasis screening in the era of positron emission tomography‐CT staging: Current practice and outcomes | Journal of Medical Imaging and Radiation Oncology | 2018 | 23 |
| 34 | Inter‐ and intra‐fraction motion in stereotactic body radiotherapy for spinal and paraspinal tumours using cone‐beam CT and positional correction in six degrees of freedom | Journal of Medical Imaging and Radiation Oncology | 2016 | 21 |
| 35 | An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer | Radiotherapy and Oncology | 2022 | 21 |
| 36 | Single versus multiple session stereotactic body radiotherapy for spinal metastasis: the risk–benefit ratio | Future Oncology | 2015 | 20 |
| 37 | Radiotherapy for node-positive prostate cancer: 2019 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group | Radiotherapy and Oncology | 2019 | 20 |
| 38 | An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes | Journal of Investigative Dermatology | 2019 | 19 |
| 39 | Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate? | Current Treatment Options in Oncology | 2021 | 19 |
| 40 | Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin | International Journal of Clinical Oncology | 2005 | 18 |
| 41 | Results of a phase II, open‐label, non‐comparative study of intralesional PV‐10 followed by radiotherapy for the treatment of in‐transit or metastatic melanoma | Journal of Surgical Oncology | 2017 | 18 |
| 42 | Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma – Initial Experience From an Australian Liver Cancer Service | Clinical Oncology | 2020 | 17 |
| 43 | The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial | Clinical and Experimental Metastasis | 2020 | 16 |
| 44 | Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium | Journal of Gastroenterology and Hepatology (Australia) | 2021 | 16 |
| 45 | Radiation-induced primary cerebral atypical teratoid/rhabdoid tumour in an adult | Journal of Clinical Neuroscience | 2013 | 15 |
| 46 | An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases | Radiotherapy and Oncology | 2021 | 14 |
| 47 | The effect of beam arrangements and the impact of non‐coplanar beams on the treatment planning of stereotactic ablative radiation therapy for early stage lung cancer | Journal of Medical Radiation Sciences | 2016 | 13 |
| 48 | Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy | Clinical and Experimental Metastasis | 2016 | 13 |
| 49 | Evaluation of a telehealth psychological support intervention for people with primary brain tumour and their family members: Study protocol for a randomised controlled trial | European Journal of Cancer Care | 2019 | 13 |
| 50 | Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand | JAMA Network Open | 2021 | 13 |
